About Careers Internship MedBlog Contact us

Blood Group ‘O’ Defends Against Severe Malaria

by VR Sreeraman on November 7, 2007 at 1:20 PM
Blood Group ‘O’ Defends Against Severe Malaria

Scientists have found that blood group O can be a defence against the development of severe, life-threatening malaria in children, the science site SciDev.Net reports.

They hope their discovery may prove useful in finding a treatment for severe malaria in children with other blood groups.


Their work is published in the Oct 30 issue of the Proceedings of the National Academy of Sciences.

The team, led by Alex Rowe of the University of Edinburgh in Britain, took blood samples from children with severe malaria, children with less serious malaria and healthy children in Bandiagara, Mali.

They found that children with group O blood were 66 percent less likely to develop severe malaria than children with A and B blood groups.

The blood of group O children contained far fewer clumps, or 'rosettes', of red blood cells than their non-O counterparts.

Rosettes appear when red blood cells infected with the malaria parasite - Plasmodium falciparum - stick to uninfected red blood cells, possibly to hide the parasite from the host's immune system.

Rosetting contributes to severe malaria by blocking the flow of blood through small blood vessels. "In the blood group O children there was very little rosetting at all," says Rowe.

"The study confirms for us the importance of rosetting in severe malaria. If we can modify rosetting so that we can make children who are A or B behave like those with group O - with very few rosettes - that could be a useful treatment for the most severely ill children," she adds.

The researchers aim to develop a drug to 'break up' rosettes in the blood of children with severe malaria. They already have a candidate compound, curdlan sulphate, but this can cause bleeding.

"We're trying to develop second-generation drugs based on curdlan sulphate that will still disrupt rosettes but not cause the bleeding," says Rowe.

"It looks like we'll be able to separate those two activities and have a drug that doesn't have those side-effects - though this is still very much ongoing work."

Source: ANI
Font : A-A+



Recommended Readings

Latest General Health News

US Woman Loses All Limbs in Fish-Related Bacterial Outbreak
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
NIH Launches the First In-Human Universal Flu Vaccine Trial
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
Global Polio Eradication Initiative Assesses Vaccination Strategies in Pakistan
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Diagnostic Errors: The Rocky Road to Life-threatening Health Complications
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
Strategies To Maintain Work-Life Balance In The Digital Age
Due to our constant connectivity and the ability to be accessible at all times, it has become challenging to separate from work and fully participate in personal life.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Blood Group ‘O’ Defends Against Severe Malaria Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests